Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04539678
What this trial is testing

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

Who this might be right for
Thrombotic PatientsDiagnosis of Myeloproliferative NeoplasiaImpact of Treatment With Cytoreducing Agent
Nantes University Hospital 253
Not applicableLooking for participantsNCT07799922
What this trial is testing

IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus

Who this might be right for
IRE
Tianjin Medical University Cancer Institute and Hospital 60
Not applicableStudy completedNCT01345773
What this trial is testing

Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer

Who this might be right for
Gastric CancerVenous ThromboembolismPostoperative Period
Seoul National University Bundang Hospital 375
Testing effectiveness (Phase 2)UnknownNCT02452853
What this trial is testing

HR Combined With FOLFOX4 for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 51
Not applicableLooking for participantsNCT06960954
What this trial is testing

PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)Portal Vein Tumour Thrombosis
Tanta University 116
Not applicableStudy completedNCT07483242
What this trial is testing

Individualized Surgical Guidance in HCC-BDTT

Who this might be right for
Hepatocellular Carcinoma (HCC)
First Affiliated Hospital, Sun Yat-Sen University 151
Large-scale testing (Phase 3)Study completedNCT02774187
What this trial is testing

Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 247
Not applicableLooking for participantsNCT07399977
What this trial is testing

Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous Thrombosis
Memorial Sloan Kettering Cancer Center 259
Post-approval studies (Phase 4)Study completedNCT02444572
What this trial is testing

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®

Who this might be right for
Gastrointestinal NeoplasmsThromboembolic Event
Les Laboratoires des Médicaments Stériles 168
Not applicableStudy completedNCT02744092
What this trial is testing

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

Who this might be right for
CancerVenous ThromboembolismDeep Vein Thrombosis (DVT)+2 more
Alliance Foundation Trials, LLC. 811
Not applicableUnknownNCT05964621
What this trial is testing

Venous Thromboembolism in Primary Pancreatic Tumour Resection

Who this might be right for
Venous ThromboembolismPancreatic CancerPancreatic Ductal Adenocarcinoma
University of Thessaly 64
Not applicableUnknownNCT02913365
What this trial is testing

Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis

Who this might be right for
HemoptysisHaemoptysisLung Disease+17 more
Université de Sherbrooke 1,000
Not applicableUnknownNCT05229471
What this trial is testing

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study

Who this might be right for
CancerVenous ThromboembolismRecurrence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 220
Testing effectiveness (Phase 2)UnknownNCT04850157
What this trial is testing

Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 30
Post-approval studies (Phase 4)Study completedNCT01952353
What this trial is testing

Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion

Who this might be right for
Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Sun Yat-sen University 330
Not applicableStudy completedNCT02460445
What this trial is testing

Phlebotomy and Polycystic Ovary Syndrome

Who this might be right for
HyperandrogenismMetabolic Cardiovascular Syndrome
Manuel Luque Ramírez 37
Post-approval studies (Phase 4)UnknownNCT00450645
What this trial is testing

Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis

Who this might be right for
Deep Vein ThrombosisCancer
Azienda Ospedaliera Universitaria Policlinico 300
Testing effectiveness (Phase 2)Looking for participantsNCT05683808
What this trial is testing

Venous Thromboembolism Prevention in Outpatients With Glioma

Who this might be right for
GlioblastomaAstrocytomaVenous Thromboembolism
University of Vermont Medical Center 40
Early research (Phase 1)Study completedNCT00476216
What this trial is testing

Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerVenous Thromboembolism
University of Alabama at Birmingham 23
Not applicableWithdrawnNCT05592197
What this trial is testing

Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT

Who this might be right for
Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Next Page